Financial reports
NT 10-K
Notice of late annual filing
1 Apr 24
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
14 Jul 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K
22 Apr 24
8-K
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
5 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
16 Jan 24
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
1 Dec 23
8-K
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
28 Nov 23
8-K
Other Events
6 Oct 23
8-K
Departure of Directors or Certain Officers
27 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Sep 23
8-K
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
23 Aug 23
8-K
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
11 Aug 23
Registration and prospectus
424B3
Prospectus supplement
20 Jul 22
S-3
Shelf registration
11 Jul 22
S-8
Registration of securities for employees
25 Mar 22
424B5
Prospectus supplement for primary offering
16 Dec 21
S-8
Registration of securities for employees
11 Mar 21
S-3
Shelf registration
21 Dec 20
POS AM
Prospectus update (post-effective amendment)
8 Jun 20
POS AM
Prospectus update (post-effective amendment)
8 Jun 20
S-8
Registration of securities for employees
10 Mar 20
424B5
Prospectus supplement for primary offering
20 Dec 19
Proxies
DEFA14A
Additional proxy soliciting materials
14 Dec 22
DEFA14A
Additional proxy soliciting materials
14 Nov 22
DEF 14A
Definitive proxy
10 Nov 22
PRE 14A
Preliminary proxy
31 Oct 22
DEFA14A
Additional proxy soliciting materials
12 Apr 22
DEF 14A
Definitive proxy
12 Apr 22
PRE 14A
Preliminary proxy
1 Apr 22
DEFA14A
Additional proxy soliciting materials
22 Apr 21
DEF 14A
Definitive proxy
22 Apr 21
DEFA14A
Additional proxy soliciting materials
21 Apr 20
Other
EFFECT
Notice of effectiveness
21 Jul 22
CORRESP
Correspondence with SEC
18 Jul 22
UPLOAD
Letter from SEC
18 Jul 22
EFFECT
Notice of effectiveness
8 Jan 21
CORRESP
Correspondence with SEC
5 Jan 21
UPLOAD
Letter from SEC
23 Dec 20
EFFECT
Notice of effectiveness
10 Jun 20
EFFECT
Notice of effectiveness
10 Jun 20
CERT
Certification of approval for exchange listing
30 Jul 19
EFFECT
Notice of effectiveness
25 Jul 19